| 1 |
35158049 | Differences in advanced glycation endproducts (AGEs) in plasma from birds and mammals of different body sizes and ages. | 2022 May |
2 |
| 2 |
35487443 | Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE). | 2022 May |
1 |
| 3 |
34630686 | Effects of Psoralea corylifolia L. seed extract on AGEs-induced cell proliferation and fibrotic factor expression in mesangial cells. | 2021 Nov |
2 |
| 4 |
32112452 | Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes. | 2020 Jul |
1 |
| 5 |
32407958 | Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology. | 2020 Aug |
2 |
| 6 |
32814631 | Toll-like receptor 4 plays a key role in advanced glycation end products-induced M1 macrophage polarization. | 2020 Oct 22 |
2 |
| 7 |
32853909 | AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy. | 2020 Nov |
2 |
| 8 |
30031036 | Fatty acids and oxidized lipoproteins contribute to autophagy and innate immunity responses upon the degeneration of retinal pigment epithelium and development of age-related macular degeneration. | 2019 Apr |
1 |
| 9 |
31035509 | Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin. | 2019 Apr 26 |
2 |
| 10 |
31079281 | AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease. | 2019 Sep |
5 |
| 11 |
31491943 | Dapagliflozin Prevents NOX- and SGLT2-Dependent Oxidative Stress in Lens Cells Exposed to Fructose-Induced Diabetes Mellitus. | 2019 Sep 5 |
4 |
| 12 |
29477598 | RAGE and its emerging role in the pathogenesis of Parkinson's disease. | 2018 Apr 13 |
2 |
| 13 |
29483760 | AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease. | 2018 Mar |
1 |
| 14 |
29752466 | miR-5591-5p regulates the effect of ADSCs in repairing diabetic wound via targeting AGEs/AGER/JNK signaling axis. | 2018 May 1 |
5 |
| 15 |
28482155 | Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. | 2017 Sep 14 |
2 |
| 16 |
26201485 | Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy? | 2016 |
4 |
| 17 |
26895319 | Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism. | 2016 Mar |
4 |
| 18 |
28035243 | CML/RAGE signal induces calcification cascade in diabetes. | 2016 |
3 |
| 19 |
24978055 | Receptor for advanced glycation end-products regulates lung fluid balance via protein kinase C-gp91(phox) signaling to epithelial sodium channels. | 2015 Jan |
1 |
| 20 |
26197866 | Advanced oxidation protein products induce apoptosis in podocytes through induction of endoplasmic reticulum stress. | 2015 Sep |
1 |
| 21 |
26363473 | Oxidative stress in chronic vascular disease: From prediction to prevention. | 2015 Nov |
2 |
| 22 |
23509221 | Total plasma Nε-(carboxymethyl)lysine and sRAGE levels are inversely associated with a number of metabolic syndrome risk factors in non-diabetic young-to-middle-aged medication-free subjects. | 2014 Jan 1 |
1 |
| 23 |
23855502 | The potential mechanisms of Aβ-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer's disease. | 2014 Feb |
1 |
| 24 |
25330663 | [Effect of advanced glycosylation end products on oxidative stress and MCP-1 in human renal mesangial cells]. | 2014 Jul |
2 |
| 25 |
23776698 | Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways. | 2013 |
1 |
| 26 |
24084731 | Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. | 2013 Oct 1 |
5 |
| 27 |
24255785 | A novel hypothesis: up-regulation of HO-1 by activation of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the development of ALI/ARDS. | 2013 Oct |
1 |
| 28 |
20638753 | AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation. | 2012 Jan |
1 |
| 29 |
22864903 | Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression. | 2012 Nov |
2 |
| 30 |
21282351 | Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease. | 2011 Apr |
2 |
| 31 |
21317562 | RAGE regulates autophagy and apoptosis following oxidative injury. | 2011 Apr |
3 |
| 32 |
21388644 | Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level. | 2011 Sep |
2 |
| 33 |
21978883 | Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells. | 2011 Dec 29 |
5 |
| 34 |
20299674 | The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. | 2010 Mar 19 |
1 |
| 35 |
20492604 | Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products. | 2010 Nov |
2 |
| 36 |
19190027 | Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes. | 2009 Dec-2010 Jan |
4 |
| 37 |
19252229 | Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide. | 2009 |
1 |
| 38 |
18332897 | Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. | 2008 May |
1 |
| 39 |
18473848 | Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. | 2008 |
1 |
| 40 |
18720754 | [Dementia and diabetes mellitus]. | 2008 Mar-Apr |
1 |
| 41 |
17095586 | Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. | 2007 Feb |
1 |
| 42 |
18049312 | Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. | 2007 Oct |
5 |
| 43 |
16787220 | Novel therapeutics for diabetic micro- and macrovascular complications. | 2006 |
2 |
| 44 |
15893388 | The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells. | 2005 Jun 30 |
4 |
| 45 |
15922119 | Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders. | 2005 |
1 |
| 46 |
16018761 | Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. | 2005 Jul |
1 |
| 47 |
15553663 | Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. | 2004 |
3 |
| 48 |
12909002 | The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia. | 2003 |
1 |
| 49 |
11375353 | Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. | 2001 Jun |
1 |